These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7585886)

  • 1. Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy.
    Dayanithi G; Yahi N; Baghdiguian S; Fantini J
    Cell Calcium; 1995 Jul; 18(1):9-18. PubMed ID: 7585886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.
    Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J
    J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
    Yahi N; Sabatier JM; Baghdiguian S; Gonzalez-Scarano F; Fantini J
    J Virol; 1995 Jan; 69(1):320-5. PubMed ID: 7983725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy.
    Clayton F; Kotler DP; Kuwada SK; Morgan T; Stepan C; Kuang J; Le J; Fantini J
    Am J Pathol; 2001 Nov; 159(5):1933-9. PubMed ID: 11696454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
    Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity.
    Singhal PC; Sagar S; Chandra D; Garg P
    Am J Pathol; 1995 Jul; 147(1):25-32. PubMed ID: 7604883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line.
    Maresca M; Mahfoud R; Garmy N; Kotler DP; Fantini J; Clayton F
    J Biomed Sci; 2003; 10(1):156-66. PubMed ID: 12566994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41.
    Chirmule N; Kalyanaraman VS; Saxinger C; Wong-Staal F; Ghrayeb J; Pahwa S
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):299-305. PubMed ID: 2187499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.
    Delézay O; Koch N; Yahi N; Hammache D; Tourres C; Tamalet C; Fantini J
    AIDS; 1997 Sep; 11(11):1311-8. PubMed ID: 9302439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood.
    Sugiura K; Oyaizu N; Pahwa R; Kalyanaraman VS; Pahwa S
    Blood; 1992 Sep; 80(6):1463-9. PubMed ID: 1520872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons.
    Lannuzel A; Lledo PM; Lamghitnia HO; Vincent JD; Tardieu M
    Eur J Neurosci; 1995 Nov; 7(11):2285-93. PubMed ID: 8563977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
    Koga Y; Nakamura K; Sasaki M; Kimura G; Nomoto K
    Virology; 1994 May; 201(1):137-41. PubMed ID: 8178478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
    Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.